Kezar Life Sciences, Inc. (16)
Browse by Contract Category
Contracts
-
Non-Employee Director Compensation Policy
(Filed With SEC on March 17, 2022)
-
Loan and Security Agreement, dated as of November 4, 2021, by and between the Company and Oxford Finance LLC
(Filed With SEC on March 17, 2022)
-
Sales Agreement dated as of November 19, 2021, between the Company and Cowen and Company, LLC
(Filed With SEC on November 19, 2021)
-
Description of the Companys Securities
(Filed With SEC on March 12, 2020)
-
Confirmation of Lease Terms between the Company and AP3-SF1 4000 Shoreline, LLC, effective as of March 1, 2018
(Filed With SEC on March 26, 2019)
-
Form of Restricted Stock Unit Grant Notice and Unit Award Agreement under 2018 Equity Incentive Plan
(Filed With SEC on March 17, 2022)
-
Non-Employee Director Compensation Plan
(Filed With SEC on March 11, 2021)
-
Underwriting Agreement, dated June 8, 2020, by and among the Company, Jefferies LLC, Cowen and Company, LLC and William Blair & Company L.L.C
(Filed With SEC on June 10, 2020)
-
Executive Employment Agreement, between the Company and Vassiliki Economides, dated January 14, 2020
(Filed With SEC on May 7, 2020)
-
Executive Employment Agreement, between the Company and Noreen Henig, M.D., dated April 25, 2020
(Filed With SEC on May 7, 2020)
-
Non-Employee Director Compensation Plan
(Filed With SEC on March 12, 2020)
-
Amended and Restated Executive Employment Agreement between the Company and Marc L. Belsky, dated January 14, 2020
(Filed With SEC on March 12, 2020)
-
Underwriting Agreement, dated January 31, 2020, by and among the Company, Cowen and Company, LLC, Wells Fargo Securities, LLC and William Blair & Company L.L.C
(Filed With SEC on February 3, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on February 3, 2020)
-
Transition Services, Separation and General Release Agreement, between the Company and Niti Goel, M.D., dated August 6, 2019
(Filed With SEC on November 7, 2019)
-
Amended and Restated Executive Employment Agreement between the Company and Niti Goel, dated June 8, 2018
(Filed With SEC on May 7, 2019)